Year-over-Year Revenue Growth
Revenue increased by 18% year-over-year, driven by a 5% rise in surgical procedures utilizing the Catamaran System.
Gross Margin Improvement
Gross margin improved by 2,200 basis points, reaching 54% for the first nine months of 2024 compared to 32% in the same period of the previous year.
Successful Investment and Financial Position
Received an investment from a healthcare-focused institutional investor, along with additional equity financings, resulting in net proceeds of approximately $9.6 million, fortifying the balance sheet.
Launch of Catamaran SE
Initiated prelaunch clinical work of the new Catamaran SE, with positive feedback from physicians and a planned full commercial launch in early 2025.
Positive Clinical Data
Interim analysis showed statistically significant reduction in SI joint pain and disability, with high patient satisfaction and a robust safety profile.
New Patents Issued
Received three new patents related to the Catamaran prosthesis, strengthening the competitive position.